LivaNova (LIVN) vs Medtronic (MDT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
LivaNova (LIVN) has outperformed Medtronic (MDT) over the past year, gaining 46.6% versus a loss of 8.3%. Over five years, LIVN leads with a -8.9% price change compared with -30.7% for MDT. Medtronic is the larger company by market cap ($113.18 billion vs $4.20 billion), about 27.0 times the size, while LivaNova is growing revenue faster (+10.7% vs +8.4%).
On valuation, Medtronic trades at a lower forward P/E (13.8x vs 16.3x for LivaNova). Medtronic pays a dividend yielding 3.22%, while LivaNova does not currently pay one. Medtronic converts more of its revenue into profit, with a net margin of 13.2% versus -17.5%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LIVN | MDT |
|---|---|---|
| Share price | $76.39 | $88.48 |
| Market cap | $4.20B | $113.18B |
| 1-day change | +0.63% | +0.83% |
| YTD return | +24.15% | -7.89% |
| 1-year return | +46.59% | -8.31% |
| 5-year return | -8.94% | -30.74% |
| P/E ratio (TTM) | 22.60 | 21.58 |
| Forward P/E | 16.31 | 13.79 |
| EPS (TTM) | $3.38 | $4.10 |
| Dividend yield | 0.00% | 3.22% |
| Annual dividend | $0.00 | $2.85 |
| Revenue (latest FY) | $1.39B | $36.36B |
| Revenue growth (YoY) | +10.74% | +8.43% |
| Net income (latest FY) | $-242.47M | $4.80B |
| Gross margin | 67.71% | 65.02% |
| Operating margin | 14.36% | 17.78% |
| Net margin | -17.47% | 13.20% |
| 52-week high | $85.76 | $106.33 |
| 52-week low | $48.82 | $73.31 |
| Distance from 52-week high | -10.93% | -16.79% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +18.54% | +18.04% |
| Average volume | 648.38K | 13.05M |
| Shares outstanding | 54.93M | 1.28B |
| Employees | 3,300 | 95,000 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Medtronic is about 27.0 times larger than LivaNova by market value ($113.18B vs $4.20B).
- LIVN has outperformed MDT by 54.9 percentage points over the past year.
- Medtronic offers a meaningfully higher dividend yield (3.22% vs 0.00%).
- Medtronic is more profitable, keeping 13.2 cents of every revenue dollar as net income versus -17.5 cents for LivaNova.
About LivaNova
LIVN stock →LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 3,300 employees
About Medtronic
MDT stock →Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 95,000 employees
LIVN vs MDT FAQ
Which is bigger, LivaNova or Medtronic?
Medtronic (MDT) is larger, with a market capitalization of $113.18B compared with $4.20B for LivaNova (LIVN).
Which stock has performed better over the past year, LIVN or MDT?
LIVN returned +46.59% over the past 12 months, compared with -8.31% for MDT (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, LIVN or MDT?
MDT has the lower trailing P/E at 21.6, versus 22.6 for LIVN. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, LivaNova or Medtronic?
Medtronic pays a dividend yielding 3.22%, while LivaNova does not currently pay a regular dividend.
Are LivaNova and Medtronic in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.